HIGHLIGHTS
- who: Sheefa Mirza and collaborators from the University Hospital of Parma, Italy have published the Article: Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?, in the Journal: (JOURNAL)
- what: All the research conferred so far in CRC are focused either on the association between ctDNA existence and tumor burden or the recognition of molecular modifications that predict response or resistance to targeted agents.
- how: The authors hypothesized that CTC research should be commenced concurrently with other TME components such as cancer associated fibroblasts (CAFs) various immune . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.